title: Reply to 'Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib' by Pilot et al.
authors.affiliation: 1Department of Oncology-Hematology and Cell Therapy, Clinical Research Centre, Poitiers, France.
authors.forename: L
authors.initials: L
authors.lastname: Roy
authors.forename: J
authors.initials: J
authors.lastname: Guilhot
authors.forename: G
authors.initials: G
authors.lastname: Martineau
authors.forename: F
authors.initials: F
authors.lastname: Guilhot